| Characteristic | Cannabis | Cocaine | Ecstasy/MDMA* | Hallucinogenic mushrooms | Amphetamines* | Heroin |
|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
| - | - | - | - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Sources
Release date
June 2024
Region
France
Survey time period
June 2024
Number of respondents
14,984 respondents
Age group
18-75 years
Special properties
Metropolitan France
Method of interview
CATI, online interview
Supplementary notes
*The use of ecstasy/MDMA and amphetamines was not captured by the sources in the 1992 and 1995 surveys.
Citation formats








